what is glp 1 retatrutide for weight loss: Study shows 30% body weight loss Diagram showing the mechanism of

Injection site reactions (redness, itching, small nodules) were observed in roughly 5-15% of participants

Body composition outcomes matter

This triple-agonist mechanism allows it to influence several interconnected hormonal systems

Bereken je BMI als eerste stap via onze BMI-calculator

The most common side effects are gastrointestinal , including: Nausea Bloating Constipation Diarrhea Vomiting These tend to go away after the first few weeks of treatment or during dose increases when your digestive system adapts to the medication

It is often described as a triple agonist because it targets GLP-1, GIP, and glucagon pathways